Biotin and Ceftazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Biotin (biotin) and Ceftazidime (ceftazidime). Common drug interactions include weight increased among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Biotin and Ceftazidime. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

15 people who take Biotin and Ceftazidime together, and have interactions are studied.

Biotin and Ceftazidime drug interactions.

What are the common drug interactions of Biotin and Ceftazidime, by gender? *:

female:

Weight increased
Cough
Gait disturbance
Weight decreased
Blood glucose decreased
Bone marrow failure
Dyspnoea (difficult or laboured respiration)
Fall
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

Anxiety
Arthralgia (joint pain)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Tooth extraction
Tooth loss
Bone density decreased
Bone loss
Bone pain

What are the common drug interactions of Biotin and Ceftazidime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Bone marrow failure
Immunodeficiency
Renal impairment (severely reduced kidney function)
Staphylococcal infection (an infection with staphylococcus bacteria)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)

10-19:

n/a

20-29:

Anxiety
Arthralgia (joint pain)
Bone density decreased
Bone loss
Bone pain
Chronic kidney disease
Depression
Emotional distress
Mobility decreased (ability to move is reduced)
Nerve injury

30-39:

n/a

40-49:

Neoplasm malignant (cancer tumour)
Uterine cancer

50-59:

n/a

60+:

Back pain
Burns second degree
Pneumonia viral
Productive cough
Respiratory syncytial virus infection (viral disease of respiratory system)
Sinusitis (inflammation of sinus)
Skin exfoliation (removal of the oldest dead skin cells)
Skin infection
Sputum discoloured
Upper limb fracture

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 20.00%
Immunodeficiency Common Variable: 3 people, 20.00%
Cystic Fibrosis (disease of the secretary glands): 3 people, 20.00%
Diabetes: 3 people, 20.00%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 3 people, 20.00%
Acute Kidney Failure: 3 people, 20.00%
Immunodeficiency: 2 people, 13.33%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 13.33%
Vitamin B1 Deficiency: 2 people, 13.33%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and Ceftazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously